Elevated TMAO levels linked to higher diabetes risk, study finds

FHS
June 5, 2024
12:51 am

A recent Nutrients study links elevated trimethylamine N-oxide (TMAO) levels with an increased risk of type 2 diabetes, highlighting the role of diet in diabetes prevention.

Diagnostic performance of GPT-4 in analyzing radiology findings from brain tumors

GPT-4 demonstrates diagnostic capabilities in brain radiology, achieving 73% accuracy for final diagnoses and 94% for differential diagnoses in recent research.

October 3, 2024

Year in Review: Obesity

This year’s headlines featured new FDA approvals, investigational drugs that scored success in major trials, new bariatric surgery benefits, and questions on the clinical utility

December 2, 2023

FDA OKs New Frontline Endometrial Cancer Regimen, First in Decades

The FDA approved the immune checkpoint inhibitor dostarlimab (Jemperli) plus chemotherapy as a frontline option for certain patients with advanced or recurrent endometrial cancer, the

August 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.